News
Two NIH Technology Transfer experts will be speaking at the Biotechnology Innovation Organization 2025 International Convention taking place in Boston, June 16-19, 2025, with pre-conference sessions taking place June 14-15. Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer
Register today for NCI’s webinar on an available COVID-19 vaccine that recently completed a study demonstrating how the vaccine prevented SARS-CoV-2 transmission and infection. Current SARS-CoV-2 vaccines utilize an intramuscular injection, while this technology combines an intramuscular injection
The National Cancer Institute (NCI) is seeking a collaboration partner for a COVID-19 therapeutic that will stop the infected cells from replicating inside a host. When SARS-CoV-2 enters a host, the cells replicate it and viral particles invade the nearby healthy cells. This happens because SARS-CoV
Louis Staudt, M.D., Ph.D. was recently awarded the Career Achievement Award, which recognizes ten or more years in HHS and dedication and loyalty to the Department. Dr. Staudt is the Chief of the Lymphoid Malignancies Branch at NCI. Dr. Staudt pioneered the use of gene expression profiling to